SCHEMBL180290

SCHEMBL180290

C=C(C)C1CCC(C)=CC1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 10/20 0.53
CNR2 P34972 9/20 0.49
OPRM1 P35372 6/20 0.49
GPR55 Q9Y2T6 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
TRPA1 O75762 1/20 0.47
CYP1A1 P04798 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2B6 P20813 1/20 0.47
SLC6A2 P23975 1/20 0.47
CYP2C19 P33261 1/20 0.47
GPR6 P46095 1/20 0.47
SLC6A3 Q01959 1/20 0.47
NAAA Q02083 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
TRPV3 Q8NET8 1/20 0.47
TRPV4 Q9HBA0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5904277 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL25933425 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL21759190 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL20835188 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL4299443 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL23847917 1.00 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL14215885 0.90 CNR1 (0.46) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL8521177 0.80 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL31545513 0.80 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1
SCHEMBL19852268 0.80 CNR1 (0.53) CNR1CNR2OPRM1GPR55MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049067-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl 3 * 6H2O AS CATALYST SALUD & SEMILLAS S L (ES) 2026-02-19 US claimed
US-20250282743-A1 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CITRACHEM CORP. 2025-09-11 US claimed
EP-4565573-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST Salud & Semillas, S.L. (ES) 2025-06-11 EP claimed
CN-119798060-A Method for preparing citronellal 万华化学集团股份有限公司 2025-04-11 CN claimed
EP-4469426-A2 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CitraChem Corp. (US) 2024-12-04 EP claimed
US-20240083829-A1 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF ISOPIPERITENOL STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-03-14 US claimed
WO-2024028516-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST SALUD & SEMILLAS, S.L. (ES) 2024-02-08 WO claimed
EP-4288448-A1 TERPENE PRODUCTION IN PLANTS Altria Client Services LLC (US) 2023-12-13 EP claimed
EP-4247777-A1 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF ISOPIPERITENOL Studiengesellschaft Kohle gGmbH (DE) 2023-09-27 EP claimed
WO-2023147057-A2 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CITRACHEM CORP. (US) 2023-08-03 WO claimed
EP-4023626-A1 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF ISOPIPERITENOL Studiengesellschaft Kohle mbH (DE) 2022-07-06 EP claimed
WO-2021237371-A1 PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS MCMASTER UNIVERSITY (CA) 2021-12-02 WO claimed
US-20140308216-A1 ANTIMICROBIAL COMPOSITION DOW GLOBAL TECHNOLOGIES LLC 2014-10-16 US claimed
EP-2787828-A1 ANTIMICROBIAL COMPOSITION Unilever N.V. (NL) 2014-10-15 EP claimed
WO-2013083592-A1 ANTIMICROBIAL COMPOSITION UNILEVER N.V. (NL) 2013-06-13 WO claimed
EP-1713922-B1 Process for producing flavor-active terpenes MAXENS GMBH (DE) 2012-01-04 EP claimed
US-7803606-B2 Method for the production of flavor-active terpenes MAXENS GMBH (DE) 2010-09-28 US claimed
US-20070172934-A1 Method for the production of flavor-active terpenes MAXENS GMBH (DE) 2007-07-26 US claimed
EP-1713922-A1 METHOD FOR THE PRODUCTION OF FLAVOR-ACTIVE TERPENES Maxens GmbH (DE) 2006-10-25 EP claimed
WO-2005078110-A1 METHOD FOR THE PRODUCTION OF FLAVOR-ACTIVE TERPENES MAXENS GMBH (DE) 2005-08-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083829-A1 PROCESS FOR THE ASYMMETRIC SYNTHESIS OF ISOPIPERITENOL COASY, DHPS, GGPS1 CNR1 3032/4885CNR2 3540/4885OPRM1 3871/4885
US-20250282743-A1 METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS CNR2, CNR1, CYP8B1 CNR1 2/4885CNR2 1/4885OPRM1 16/4885
US-20260049067-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl 3 * 6H2O AS CATALYST MGLL, CNR2, DAGLA CNR1 6/4885CNR2 2/4885OPRM1 50/4885
US-20140308216-A1 ANTIMICROBIAL COMPOSITION TMSB10, POLR1C, TAS2R40 CNR1 4475/4885CNR2 4404/4885OPRM1 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.